Publications by authors named "Maria Teresa Farina"
Article Synopsis
- Polycystic kidney diseases (PKD) are significant contributors to chronic kidney disease, with autosomal dominant PKD (ADPKD) being the most prevalent form, while a new atypical form caused by DNAJB11 mutations has been identified.
- A study compared 27 patients with DNAJB11-PKD to 42 typical ADPKD patients, revealing that DNAJB11-PKD patients had smaller kidneys and cysts, and progressed more slowly to end-stage kidney disease.
- The findings indicated that DNAJB11-PKD presents unique clinical features, such as older age and higher rates of type 2 diabetes and kidney stones, suggesting that it should be classified separately from
Article Synopsis
- - The study investigates the use of ultrasound (US) to assess changes in quadriceps muscle thickness in critically ill patients with acute kidney injury (AKI) during their first 5 days in the ICU.
- - A total of 30 eligible patients were monitored, revealing an average muscle thickness decrease of 15% within that time frame, indicating significant muscle wasting.
- - Patients who experienced greater muscle loss showed a lower likelihood of being discharged home, highlighting the importance of muscle monitoring for patient outcomes.
Article Synopsis
- - This study looked at the effectiveness of colchicine in treating COVID-19 by comparing outcomes between 71 patients who received the drug and 70 who did not.
- - Results showed that patients on colchicine had significantly lower mortality (7.5% vs. 28.5%) and improved clinical recovery compared to the control group, suggesting it helps counteract severe inflammation.
- - The findings indicate that colchicine might reduce death rates and aid recovery in COVID-19 patients, supporting the need for larger studies to further explore its safety and efficacy.
The epidemic wave that hit Italy from February 21st, 2020, when the Italian National Institute of Health confirmed the first case of SARS‑CoV‑2 infection, led to a rapid and efficient reorganization of Dialysis Centers' activities, in order to contain large-scale spread of disease in this clinical setting. We herein report the experience of the Hemodialysis Unit of Parma University Hospital (Azienda Ospedaliero-Universitaria, Parma, Italy) and the Dialysis Centers of Parma territory, in the period from March 1st, 2020 to June 15, 2020. Among patients undergoing chronic haemodialysis, 37/283 (13%) had positive swabs for SARS‑CoV‑2, 9/37 (24%) died because of COVID-19.
View Article and Find Full Text PDF